| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | cholic acid 3,7,12-triacetate | 52840-09-2 | C30H46O8 | 534.69 |
| 胆酸 | cholate | 81-25-4 | C24H40O5 | 408.579 |
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | 3α,7α,12α-triacetoxy-5β-cholestane | 1413404-40-6 | C33H54O6 | 546.788 |
| —— | 7α,12α-diacetoxy-5β-cholestan-3α-ol | 1448262-80-3 | C31H52O5 | 504.751 |
| —— | (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-17-((R)-5-oxopentan-2-yl)hexadecahydro-1H-cyclopenta[a] phenanthrene-3,7,12-triyl triacetate | 87899-19-2 | C30H46O7 | 518.691 |
| —— | 23-al-24-nor-5β-cholan-3α,7α,12α-triol-3α,7α,12α-triacetate | 51102-06-8 | C29H44O7 | 504.664 |
| —— | 3α,7α,12α-triacetoxy-5β-cholest-24-ene | 142533-07-1 | C33H52O6 | 544.772 |
| —— | 3-oxo-7,12-diacetate | 120174-41-6 | C31H50O5 | 502.735 |
| —— | [(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-diacetyloxy-10,13-dimethyl-17-[(2R)-5-methylsulfonyloxypentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | 947318-66-3 | C31H50O9S | 598.799 |
| —— | 7α,12α-diformyloxy-5β-cholestan-3-one | 1448262-81-4 | C29H46O5 | 474.681 |
| 7alpha,12alpha-二羟基-5beta-胆甾烷-3-酮 | 7α,12α-dihydroxy-5β-cholestan-3-one | 547-97-7 | C27H46O3 | 418.66 |
Steroidal and adamantane aminoacridine derivatives were prepared and tested as both botulinum neurotoxin (BoNT) inhibitors and antimalarials. Steroid-bound acridines provided good potency against both the BoNT/A and BoNT/B light chains (LCs). The observed inhibition of the BoNT/B LC by ca. 50% is the highest attained inhibitory activity against this serotype by acridine-based compounds to date. With respect to antimalarial activity, adamantane acridines were the most potent derivatives (IC50 = 6-9 nM, SI > 326), indicating that an adamantyl group is a better carries than a steroidal motif for this indication.